评估白病患者的Helicobacter pylori和小肠细菌过度生长的情况
Jessie M Nelson1, Jason M Rizzo2, Rachel K Greene1
1Dermatology, University of Michigan, Ann Arbor, USA.
Cureus
|November 25, 2024
概括
小肠细菌过度生长 (SIBO) 在病患者中比一般人群中更为常见. 这一发现表明SIBO和疹之间存在潜在联系,为治疗提供了新的途径.
科学领域:
- 皮肤病学 皮肤病学
- 胃肠病学 胃肠病学
- 微生物学 微生物学
背景情况:
- 系统性免疫异常可能会影响粉红的发展.
- 以前的研究表明,粉红病与细菌过度生长之间存在联系,包括Helicobacter pylori (H. pylori) 和小肠细菌过度生长 (SIBO),但研究结果不一致.
- 不一致的测试方法和混因素导致现有文献中的差异.
研究的目的:
- 为了调查H. pylori和SIBO在粉红病患者中的患病率.
- 为了控制H. pylori和SIBO流行率的评估中的潜在混因素.
- 为了探索SIBO和粉红病之间的关联.
主要方法:
- 一项涉及患者的横截面研究,该研究涉及患有斑点斑点性或红色斑块性疹性粉红病的患者.
- 排除具有先前存在的胃肠道疾病,胃肠道手术,自身免疫性疾病,免疫抑制或重大并发症的参与者.
- 针对特定药物的标准化洗期和粉红病/胃肠道健康的评估.
- 使用13C尿素呼吸和葡萄糖呼吸测试分别检测H. pylori和SIBO.
主要成果:
- 在27名粉红患者中,14.8%的H. pylori和33.3%的SIBO检测呈阳性.
- 与一般人群相比,H. pylori的流行率在粉红队列中较低 (p=0.02).
- 与一般人群相比,SIBO患病率在粉红队列中明显高 (p<0.001).
- 在人口统计,粉红病严重程度或胃肠道症状与H. pylori或SIBO阳性之间没有发现显著的关联.
结论:
- 在控制混因子后,SIBO在疹患者中更为普遍,这表明存在潜在的关联.
- SIBO和粉红病理生理学的确切关系尚不清楚;SIBO可能导致粉红,或者两者都可能是免疫系统异常的结果.
- 观察到的关联需要进一步调查,并可能为粉红病提供新的治疗点.
相关概念视频
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
89
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
89
Assessment of the Gastrointestinal System I: Subjective Data
146
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
146
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
328
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
328
Serum Laboratory Studies, Stool Test, Breath Test
316
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
316
Peptic Ulcer Disease I: Introduction
139
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
139
Gastritis III: Clinical Manifestations and Management
158
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
158


